InsiderFlow

Michael P Dube

NTLA

Michael P Dube serves as officer: VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$207.4K

Net Position

Net Seller

$207.4K

Companies Traded

1

NTLA

Active Period

Oct 2024 – Oct 2026

7 total trades

Most Recent

Sell NTLA

Oct 6, 2026 · $23.2K

Michael P Dube's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

7 · $207.4K

Total Shares Bought

0

Total Shares Sold

15,252

NTLA Price Chart
Loading chart...
DateTypeValue
Oct 6, 2026 Sell$23.2K
Jul 6, 2026 Sell$44.3K
Jan 5, 2026 Sell$27.5K
Oct 1, 2025 Sell$32.5K
Jul 2, 2025 Sell$24.9K
Jan 7, 2025 Sell$16.7K
Oct 4, 2024 Sell$38.2K